LY01011

· Luye Pharma Group Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY01011, covering 2021-06-07 to 2021-06-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid Tumors [Phase 3]